Literature DB >> 25220573

Role of ultrasound in assessing remission in rheumatoid arthritis.

K Ben Abdelghani1, S Miladi2, L Souabni1, S Kassab1, S Chekili1, A Laatar1, L Zakraoui1.   

Abstract

INTRODUCTION: Remission is the ultimate goal of the treatment of rheumatoid arthritis (RA). However, the diagnosis of remission might still be vague. Musculoskeletal ultrasound (US) seems to effectively assess synovitis, effusion and bone damage. Thus, its role could be relevant for the diagnosis, monitoring or detection of relapse in the follow-up of RA in remission. The goal of this review of the literature was to clarify the added value of ultrasonography during remission.
METHODS: A systemic search of the literature was performed on Medline and Scopus. The following key words were used: rheumatoid arthritis, remission, US. Fifty-six papers were collected, then after an in depth analysis, twelve articles were selected for analysis.
RESULTS: Twelve papers were identified that assessed remission in RA. Remission criteria varied from one author to another. The number of joints assessed by US varied from six to 44 with the wrist and metacarpo-phalangeal joints of the dominant hand scanned at least. Irrespective of remission criteria, all authors demonstrated that US detected Doppler positive synovitis in patients in clinical remission. Also, power Doppler synovitis predicted structural damage and future flares of RA.
CONCLUSION: US seems to be more effective than a clinical exam. True remission in RA must be defined. Moreover, the inclusion of this technique in the new definition of remission is being validated. Crown
Copyright © 2014. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Remission; Rheumatoid arthritis; Ultrasound

Mesh:

Year:  2014        PMID: 25220573     DOI: 10.1016/j.diii.2014.07.006

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  9 in total

1.  Ultrasound7 versus ultrasound12 in monitoring the response to infliximab in patients with rheumatoid arthritis.

Authors:  Xiaomei Leng; Weiguo Xiao; Zhonghui Xu; Xiaochun Zhu; Yi Liu; Dongbao Zhao; Huji Xu; Guoqiang Chen; Wei Yu; Jing Lu; Jiakai Wang; Xiaoru Xia; Yongji Li; Yi Zhao; Honghu Tang; Yeqing Shi; Jun Bao; Ling Chen; Li Lin; Ling Zhou; Hongwei Zhang; Yan Zhao
Journal:  Clin Rheumatol       Date:  2016-01-19       Impact factor: 2.980

2.  Impact of ultrasonography on treatment decision in rheumatoid arthritis: the IMPULSAR study.

Authors:  Cèsar Díaz-Torné; Carme Moragues; Elide Toniolo; Carme Geli; Iván Castellví; Patricia Moya; Ignasi Gich; Josep M Llobet
Journal:  Rheumatol Int       Date:  2017-03-03       Impact factor: 2.631

3.  Ultrasound of knee osteoarthritis: interobserver agreement and correlation with Western Ontario and McMaster Universities Osteoarthritis.

Authors:  Ahmed Abdel Khalek Abdel Razek; Sherif Refaat El-Basyouni
Journal:  Clin Rheumatol       Date:  2015-06-20       Impact factor: 2.980

4.  Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis.

Authors:  Chao Sun; Xuan Qi; Yushu Yang; Lingyan Lei; Lixia Gao; Huifang Guo
Journal:  Clin Rheumatol       Date:  2022-01-18       Impact factor: 2.980

5.  Rheumatoid shoulder assessed by ultrasonography: prevalence of abnormalities and associated factors.

Authors:  Imane Elbinoune; Bouchra Amine; Moudjibou Wabi; Hanan Rkain; Souad Aktaou; Najia Hajjaj-Hassouni
Journal:  Pan Afr Med J       Date:  2016-07-13

6.  Ultrasonographic findings of rheumatoid arthritis patients who are in clinical remission.

Authors:  Hadi Karimzadeh; Mehdi Karami; Nasrin Bazgir; Mansour Karimifar; Ghasem Yadegarfar; Zohrea Mohammadzadeh
Journal:  J Res Med Sci       Date:  2018-04-26       Impact factor: 1.852

7.  Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis.

Authors:  Ling Zhou; Geng Wang; Xin Liu; Jing Song; Ling Chen; Huji Xu
Journal:  Arthritis Res Ther       Date:  2017-11-15       Impact factor: 5.156

8.  Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels.

Authors:  Murat Torgutalp; Mucteba Enes Yayla; Didem Sahin Eroglu; Ayse Bahar Kelesoglu Dincer; Emine Uslu Yurteri; Ilyas Ercan Okatan; Serdar Sezer; Emine Gozde Aydemir Guloksuz; Ebru Us; Tahsin Murat Turgay; Gulay Kinikli; Askin Ates
Journal:  Mediterr J Rheumatol       Date:  2021-02-15

Review 9.  Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review.

Authors:  Hanna Gul; Kate Harnden; Benazir Saleem
Journal:  Healthcare (Basel)       Date:  2021-12-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.